Announcements
6 December 2024
MDPI INSIGHTS: The CEO's Letter #18 - MDPI UK, Basel Job Fair, CETEF'24
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI’s First UK Summit Held in Manchester
On 29 November, we hosted our first annual MDPI UK Summit, bringing together over 30 Chief Editors and Editorial Board Members (EBMs) to discuss MDPI’s mission, achievements, and collaborations in the UK.
Throughout the day we had talks from several members of MDPI, roundtable discussions on the peer-review process and upholding research integrity, and an engaging presentation from the Editor-in-Chief (EiC) of MDPI journal Mathematics, Francisco Chiclana, about his involvement with the Research Excellence Framework.
“This was a great first summit for MDPI UK and received excellent feedback”
In the following I highlight some of the sessions and the discussion topics covered in each session.
Session 1: Opening Speech and Introduction to MDPI
I shared an overview of MDPI’s mission, achievements, and commitment to quality. The Q&A touched on key topics such as perception and reputation management, expanding our arts and humanities portfolio, and funding challenges for open access (OA) in the UK.
A takeaway from this session was that in 2025, we will circulate a mini annual report to all editors, helping them understand MDPI’s mission and achievements beyond the context of their specific journals.
Session 2: MDPI and the Research Excellence Framework (REF)
Prof. Francisco Chiclana (EiC of Mathematics) highlighted MDPI’s role in REF, its purpose, and future directions.
Session 3: Editorial Process, Ethics, and Research Integrity
Dr. Giulia Stefenelli presented on the various editorial roles and responsibilities, quality metrics, and procedures for dealing with misconduct. The Q&A centred on AI in publishing, institutional roles in research integrity, and better data management practices.
Session 4: Institutional Open Access Program (IOAP)
Becky Castellon presented on IOAP benefits, including MDPI’s partnership with JISC, which includes more than 60 UK institutions, and highlighted the advantages of pure OA over transformative agreements.
Session 5: Round Table Discussion
Colleagues from our MDPI Manchester office Jaime Anderson and Dr. Michael O’Sullivan, along with colleagues from our Basel office Damaris Critchlow and Giulia Stefenelli, discussed innovations in peer review, challenges in maintaining scientific integrity, and future solutions.
Session 6: MDPI PR and the Voice of the Customer
I recapped our customer satisfaction drivers, including speed and editorial support. I also spoke about tackling misinformation about OA and MDPI in general, and outlined a way forward for us all to participate in advocating for open science.
This was a great first summit for MDPI UK and received excellent feedback from our EiCs, SEiCs, and EBMs. A BIG thank-you to our Manchester team (pictured below) and everyone else involved in organizing this event. Their hard work and dedication are much appreciated!
Impactful Research
MDPI and UK Publications
The UK is an important market for MDPI, ranking ninth in total submissions to MDPI and eighth in total MDPI publications, with over 72,200 publications to date. As at October 2024, there were more than 3,600 EBMs from the UK, 48% of whom have an H-index above 26. We also have 46 EiCs, and 63 SEiCs in the UK, some of whom joined us in Manchester for the UK Summit.
The UK is a strong advocate of OA publishing, with nearly three quarters of all articles in 2023 published on open access platforms. The country enjoys a large academic market, producing high-quality papers, and is home to some of the world’s top universities. Among MDPI’s 825 IOAP agreements, over 60 of these are in the UK, facilitated through our partnership with JISC.
“The UK is a strong advocate of OA publishing”
Visit to MDPI’s Manchester Office
Last week, I visited our Manchester office to see the expanding office space, connect with our staff, and present at the MDPI UK Summit held in Manchester.
Throughout the day, I met with various teams to better understand their work and discuss their future development plans in greater depth. Hearing from group leads about the progress we have made and the challenges we face offered many valuable insights. I also had the chance to connect personally with members of the content team. It’s great to see how this young and ambitious team is coming together.
I also took the opportunity to address the entire office about the role of MDPI UK within the wider company. During this session, I answered questions about growth and public relations initiatives. Giulia Stefenelli joined us to address questions about the role of AI in MDPI’s future.
Jaime Anderson (Office Manager) and the Manchester team have done a great job of growing the office since its establishment in 2019. Today, it has around 150 staff members across various departments, including English editing, editorial services, marketing and communications, and IOAP. The team is highly active in local marketing initiatives, such as author training sessions, scholar visits, and conferences.
For more information and updates on our Manchester office, follow MDPI UK on LinkedIn.
Inside MDPI
Basel Job Fair
In November, the HR team from our Basel office connected with over 300 young professionals at the Basel Job Fair 2024. This is my biased opinion, of course, but we had the best branded booth and merchandise, which drew a lot of attention from young talent wanting to learn about current and future job opportunities at MDPI.
Our HR team also helped review CVs on the spot, providing advice on how to improve them and making a positive impression on the future workforce in Basel.
This is a reminder that MDPI is not only focused on supporting young researchers but that we also recruit and develop young talent. We have seen MDPI HR do this really well throughout all of our offices, from Asia Pacific to Europe and North America.
HR plays an important role in our growing company, helping us meet our recruitment targets as well as providing support for local teams, guidance on management and best practices, a safe space for employees, and brand recognition for MDPI, among many other things.
“MDPI is not only focused on supporting young researchers: we also recruit and develop young talent”
This is a quick appreciation post to all HR staff working to support MDPI and our colleagues, cultivating talent and supporting careers at every stage. Thanks HR staff, keep up the great work!
Coming Together for Science
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life (The 20th Anniversary)
I am pleased to share that the Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life took place from 27 to 29 November 2024 in Barcelona, Spain. It was chaired by Prof. Dr. Amelia Pilar Rauter from the Universidade de Lisboa, Portugal; Dr. Alfredo Berzal Herranz from Instituto de Parasitología y Biomedicina López-Neyra (IPBLN) CSIC, Spain; and Prof. Dr. Mary Jane Meegan from Trinity College Dublin, Ireland.
The conference took place in Casa Convalescència, a part of the Sant Pau Art Nouveau Site. The three-day event included three plenary sessions and eight invited speakers, from eight countries, and 29 selected talks. Of the presentations on site, there were 32 posters and 29 oral presentations.
The main goal of the ‘Pharmaceuticals 2024’ international conference was to cover the newest technologies and research areas including medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, in a meeting that brought together experts to present their latest findings on combatting infection, inflammation, pain, and neurodegeneration, to mention just a few of the topics that were discussed.
“The main goal of ‘Pharmaceuticals 2024’ was to cover the newest technologies and research areas”
20th Anniversary of Pharmaceuticals
The year 2024 marks the 20th anniversary of Pharmaceuticals – a journal dedicated to medicinal chemistry and related drug sciences, which is published monthly online by MDPI. To honour this milestone, we are reflecting on our past accomplishments and embarking on an exciting new chapter. This celebration is also one of the reasons why we organized the conference Pharmaceuticals 2024. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. Pharmaceuticals has published over 6,000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed for it at least once.
20th Anniversary of Pharmaceuticals: The Video
This video captures the experiences of the conference chairs, honorary guests and committee members of the conference.
Thank you to our partnering societies
A special thank-you is due to our partnering societies the Spanish Society Of Medicinal Chemistry (SEQT) and the Spanish Society For Biochemistry And Molecular Biology (SEBBM) for their support of the Pharmaceuticals 2024 conference. I am also pleased to report that we presented two awards, sponsored by the journal Pharmaceuticals, including the Best Presentation Award and the Best Oral Presentation Award, recognizing the contributions of our participants.
Closing Thoughts
Presenting at the 4th Central European Technology Forum
I visited Krakow, Poland in November to participate in the 4th Central European Technology Forum (CETEF’24), which took place on 18 and 19 November.
CETEF is an international conference that has been jointly organized since 2014 by the Polish Chamber of Commerce for Advanced Technologies (IZTECH) and the Polish Federation of Engineering Associations, with the support of the European Parliament and the European Commission, in cooperation with universities, research institutes and the high-tech industry. The 2024 event focused on presentation to advance the European science and technology agenda for 2025–2030.
MDPI participated as a key publishing sponsor. We had an exhibition booth and held two key presentations during the conference. On Monday, I presented MDPI’s vision, purpose, and achievements.
On Tuesday, Dr. Giulia Stefenelli shared how MDPI supports advancements in high technology and energy transition, highlighting our portfolio, services, tools and initiatives for promoting progress and interdisciplinary collaboration.
We received positive feedback from scientists and government representatives in attendance.
A big thank-you goes to our colleagues from the Krakow office for their support in organizing our participation and managing the MDPI booth.
Special thanks are owing to Weronika Gorka-Kumik, Igor Matic, Vincent Di, Agnieszka Rydz, Ksenia Shubenkova, Anna Krakowka and Klaudia Kasprowicz.
Below is a photo with the President of the Polish Chamber of Commerce conference (centre), along with MDPI colleagues Giulia Stefenelli, Weronika Gorka-Kumik, and Igor Matic (left to right).
“This year’s event focused on ideas and proposals to advance the European science and technology agenda for 2025–2030”
Chief Executive Officer
MDPI AG
4 December 2024
685 MDPI Editors Named Highly Cited Researchers in 2024
22 November 2024
Antibiotics Webinar | Structural Aspects of AMPs and Antimicrobials, 3 December 2024
The world is facing an important challenge regarding the fight against multi-drug-resistant microorganisms. According to the World Health Organization (WHO), infection by microorganisms resistant to available antibiotics and antimicrobials may lead to millions of deaths every year by 2050 if advances are not made.
Various molecules have been explored as potential replacements and/or adjuvants to conventional antimicrobials. Among them, antimicrobial peptides (AMPs) and other antimicrobial polymers seem very promising due to their membranolytic activity, leading to fast and selective killing and limiting the development of resistance. In addition, in contrast with conventional antibiotics, AMPs possess additional activities (including antiviral, antifungal, anticancer, anti-inflammatory, and/or wound healing activities), making them able to potentially fight many human diseases. Indeed, many AMPs have already been used in medicine or tested in clinical trials.
The urgency to find a new antimicrobial treatment has also led to the characterization of hundreds of natural or synthetic molecules and the repurposing of molecules that were not initially identified as antimicrobial ones.
The objective of the webinar series “Structural Aspects of Antimicrobial Peptides and Antimicrobials” is to present and discuss important findings regarding the structure–activity relationship (SAR) of antimicrobial molecules, including not only AMPs but also other natural, synthetic, or repurposed antimicrobial compounds.
Date: 3 December 2024 at 2:00 p.m. CET | 10:00 a.m. Brazil | 9:00 p.m. CST Asia
Webinar ID: 812 9184 0835
Website: https://sciforum.net/event/Antibiotics-8
Register now for free!
Program:
| Speaker | Presentation Title | Time in CET | Time in Brazil | Time in CST Asia |
| Dr. Marc Maresca | Chair Introduction | 2:00–2:10 p.m. | 10:00–10:10 a.m. | 9:00–9:10 p.m. |
| Prof. Sylvie Rebuffat | The Devious Killing Strategies of Antimicrobial Peptides From Bacteria | 2:10–2:30 p.m. | 10:10–10:30 a.m. | 9:10–9:30 p.m. |
| Prof. Octavio Luiz Franco | Structural Design of Novel Antimicrobial Peptides by Using AI and Other Bioinformatic Tools | 2:30–2:50 p.m. | 10:30–10:50 a.m. | 9:30–9:50 p.m. |
| Q&A Session | 2:50–3:05 p.m. | 10:50–11:05 a.m. | 9:50–10:05 p.m. | |
| Dr. Marc Maresca | Closing of Webinar | 3:05–3:10 p.m. | 11:05–11:10 a.m. | 10:05–10:10 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Marc Maresca, Institut des Sciences Moléculaires de Marseille (ISM2) – BiosCiences – UMR 7313 CNRS Aix Marseille Université, France;
- Sylvie Rebuffat, Laboratoire Molécules de Communication et Adaptation des Microorganismes (MCAM), Muséum national d’Histoire naturelle (MNHN), Paris, France;
- Octavio Luiz Franco, 1 Center for Proteomics and Biochemical Analysis, Postgraduate Program in Genomic Sciences and Biotechnology, Catholic University of Brasília, Brasília, DF, Brazil; 2 Postgraduate Program in Biotechnology, S-Inova Biotech, Dom Bosco Catholic University, Campo Grande, MS, Brazil.
Relevant Topical Collection:
“Editorial Board Members' Collection Series: Structural Aspects of AMPs and Antimicrobials”
Collection Editors: Michael Conlo, Marc Maresca, Bong-Jin Lee and Aurélie Tasiemski
22 November 2024
Recruiting Early Career Editorial Board Members for Antibiotics
15 November 2024
Prof. Dr. A. Douglas Kinghorn Appointed Chair of the 2024 Tu Youyou Award Committee
We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.
Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA
Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.
The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.
We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.
About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.
The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.
If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.
5 November 2024
MDPI INSIGHTS: The CEO's Letter #17 - OA Week, Basel Open Day, Beijing Graphene Forum
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week: Forging the Future of Open Access through Global Reach and Collaboration
From 21 to 27 October, we celebrated International Open Access Week (OAW), highlighting the importance of making research accessible to everyone. This campaign reinforced our commitment to advancing open access (OA) and showcased how we are helping research communities worldwide adopt OA as their standard.
“OA publishing is now a cornerstone of global research”
Throughout the week, we featured MDPI’s efforts to support quality open research through blog posts on topics such as how Research Integrity Promotes OA Practices, our Preprints.org platform, and supporting societies with different OA models. These initiatives capture our commitment to making research more inclusive and accessible to all.
OA publishing is now a cornerstone of global research, with more researchers choosing OA over traditional paywalled models, and embracing new, community-driven models.
Benefits of Open Access and Open Research
- Accelerated Discoveries: OA speeds up scientific progress by allowing immediate access to findings, enabling researchers to build on each other’s work faster.
- Community-Led Innovation: Open research empowers communities to manage their own platforms, creating collaboration and shared knowledge.
- Increased Visibility: OA broadens the reach of your research, leading to greater recognition, collaboration, and impact.
- Cross-Disciplinary Connections: By removing financial and geographical barriers, OA unites diverse fields, sparking innovation across disciplines.
MDPI Singapore Celebrates Open Access Week
MDPI Singapore also hosted its first-ever OAW event at the Marina Bay Sands Convention Centre, bringing together academics, researchers, and students to discuss the future of open scholarship. Conversations focused on the potential of new publishing models, alternative funding strategies, and the importance of communicating research to wider audiences.
As OA evolves, MDPI remains a committed partner in advancing open science and creating a transparent, inclusive research environment. For a full recap of the week’s highlights and resources, visit our campaign page.
Impactful Research
MDPI Connection to Nobel-Winning Protein Research
David Baker, an American biochemist, and Demis Hassabis and John M. Jumper, two scientists from Google DeepMind, have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking advancements in better understanding the structure of proteins, the molecular engines of life’s processes.
One half of the prize was awarded to Professor David Baker from the University of Washington for his development of revolutionary protein design software enabling the creation of novel proteins for vaccines, nanomaterials, and sensors. Prof. Baker co-authored a 2016 paper in MDPI’s Toxins journal on protein-based therapeutics.
Meanwhile, DeepMind’s Demis Hassabis and John M. Jumper received recognition for AlphaFold, the AI model that predicts protein structures from amino acid sequences, fulfilling a long-held scientific dream.
“We congratulate this year’s Nobel laureates for their groundbreaking contributions to the study of life”
Nobel Prize Laureates Entrust MDPI with Their Research
As at October 2024, 45 Nobel laureates had contributed to more than 115 articles across
35 MDPI journals. The privilege of hosting the research of such contributors, who significantly influence the open access movement, resonates deeply with our editorial teams.
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath, Tomas Lindahl, Thomas C. Südhof, Stanley B. Prusiner, Roger Kornberg, Robert F. Engle, Richard J. Roberts, Ōmura Satoshi, Kenneth J. Arrow, John B. Goodenough, Jennifer Doudna, Hamilton Othanel Smith, Eric R. Kandel, Carlo Rubbia, Bernard Feringa, Barry J. Marshall, Anthony J. Leggett, Andrew Victor Schally, and David Baker.
Notable MRNA Published in Cells
On 7 October 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
MicroRNAs are proving to be fundamentally important for how organisms develop and function. Some interesting papers about microRNA research are published in the MDPI journal Cells. I invite you browse through the notable papers related to microRNA research in Cells.
Inside MDPI
Basel Open Day
On 21 October, we held the Basel Open Day at our headquarters, welcoming a group of journal Editors-in-Chief (EiC) and Editorial Board Members (EBMs) for a full-day workshop. The event featured presentations and discussions on MDPI’s latest editorial updates, data integrity policies, society collaborations, and local market insights.
The following MDPI journals were represented during the visit: Physics, Journal of Personalized Medicine (JPM), Sci, Remote Sensing, Animals, Cells, Buildings, Histories, Sensors, and International Journal of Environmental Research and Public Health (IJERPH).
This was a great opportunity to showcase our new office space while gathering feedback from leading journal stakeholders. To get everyone on the same page, we took 60 minutes for round-table introductions, which helped set a collaborative tone and ground us in MDPI’s mission of disseminating open science.
“This was a great opportunity to gather feedback from leading journal stakeholders”
The general feedback from the day highlighted positive developments around our editorial and ethics policies, as well as areas for improvement, including flexibility regarding reviewer deadlines. There was a genuine appreciation and push for our ongoing efforts to share more about MDPI, including company updates and promoting high-quality research through our blog, announcements, and social media channels, which we have been growing and expanding.
Our Basel Open Day was a positive experience, bringing together key journal stakeholders and gathering insights to guide MDPI’s continued engagement with the academic community. We look forward to hosting future events of this kind and welcoming more scholars to our headquarters in Basel, Switzerland.
Coming Together for Science
ncRNA 2024 Conference in Basel
I am pleased to share that we held Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ICM 2024) in Basel, Switzerland this past 7–9 October.
The three-day event attracted just over 100 attendees, including two Chairs, 10 invited speakers and two keynotes from Prof. Mauro Giacca and Prof. Ling-Ling Chen. Of the presentations on site, there were 35 posters and 44 oral presentations.
The overall feedback was positive, with people enjoying the intimate event and the unique activities offered, including a guided tour around Basel’s Old Town (a must-see for anyone visiting the city) and a memorable conference dinner.
It was cool to see the winners of the 2024 Nobel Prize in Physiology or Medicine announced during the conference days. This was exciting for attendees, as the winners discovered a new class of RNA molecules (miRNAs). As one invited speaker put it, “It's exciting to be among fellows when something that important for the field is announced.”
“It's exciting to be among fellows when something that important for the field is announced”
Every attendee receives a conference survey, and I’m always pleased to see a high percentage of ‘Very Satisfied’ responses when asked about ‘treatment from conference personnel’. Kudos to our conference team for meeting our attendees’ needs. These events are a great opportunity for us to reach new audiences, as 92% of the respondents had never been to an MDPI conference, so I am thrilled to see us connecting with a new demographic of your researchers in the RNA field.
A special thank-you to our partnering societies The Epigenetics Society, The French Society of Genetics, LS2 / USGEB (Union of Swiss Societies for Experimental Biology), and The RNA Biology Group, as well as to our sponsors New England Biolabs and Arraystar for their support of the ncRNA 2024 conference. I am also pleased to report that we presented two awards, including the Best Presentation Award and two Best Poster Award, recognizing the contributions of our participants.
Upcoming In-Person Event
27–29 November 2024
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
Location: Barcelona, Spain
The discovery of new molecules, their properties, and actions to enhance human health and quality of life.
Find more upcoming MDPI events here.
Closing Thoughts
Beijing Graphene Forum 2024
I am pleased to share that we had a successful time at the Beijing Graphene Forum 2024, which drew around 1,000 attendees, including Konstantin Novoselov (2015 Nobel Prize in Physics) and other high-profile scholars in materials science and chemistry. It was a great opportunity to present MDPI on the big stage, with university presidents from institutions such as Peking University also in attendance.
I had the honour of awarding Prof. Zhongfan Liu, Chairman of the Chemical Science Committee, with a medal and presenting certificates to the members of the Chemical Science Committee; this is an important initiative to help expand MDPI’s journals and influence in China. These are highly respected scholars, and we enjoyed connecting with them over lunch as well.
“This is an important initiative to help expand MDPI’s journals and influence in China”
I also had the chance to speak about MDPI and open access, giving a five-minute speech during the opening ceremony and a 20-minute presentation at the close. MDPI hosted a sub-forum where both academic scholars and MDPI members shared insights, and we engaged with attendees at our MDPI booth.
This was a great opportunity to spotlight MDPI as the main publishing partner for the event, and I was proud to represent us on stage. We also met with scholars to discuss topics such as their publishing needs and institutional policies, open access, impact journals, and IOAP.
Chief Executive Officer
MDPI AG
23 October 2024
Antibiotics Webinar | Phages and Endolysins: Uniting Global Research Across Continents, 11 November 2024
The webinar Phages and Endolysins: Uniting Global Research Across Continents explores the emerging field of bacteriophages (phages) and endolysins as novel approaches to combat pathogen bacteria. Phages, viruses that specifically target and kill bacteria, are gaining attention as potential alternatives to antibiotics, especially in the face of rising antibiotic resistance. Endolysins, enzymes produced by phages, can break down bacterial cell walls, offering another powerful tool in the fight against infections. This webinar highlights the collaborative efforts of researchers worldwide, focusing on the latest advancements in phage therapy and endolysin-based treatments. Experts discuss their potential applications in medicine, agriculture, and industry, as well as the challenges involved in bringing these therapies to clinical/industrial practice. By uniting researchers across continents, the event aims to foster international cooperation, accelerate the development of alternative antimicrobials, and address the growing threat of multidrug-resistant bacteria. Ultimately, this webinar emphasizes the global significance of phages and endolysins in shaping the future of infectious disease treatment and public health.
Date: 11 November 2024 at 2:00 p.m. CET | 9:00 p.m. CST Asia | 8:00 a.m. EST
Webinar ID: 850 3034 4057
Website: https://sciforum.net/event/Antibiotics-7
Register now for free!
Program:
| Speaker | Presentation Title | Time in CET | Time in CST Asia | Time in EST |
| Dr. Pilar García (Chair) | Chair Introduction | 2:00 – 2:10 p.m. | 9:00 – 9:10 p.m. | 8:00 – 8:10 a.m. |
| Dr. Hui Zhang | Phage Compounds Inhibit Intestinal Clostridium perfringens and Improve Immunometabolism of Microbiota | 2:10 – 2:40 p.m. | 9:10 – 9:40 p.m. | 8:10 – 8:40 a.m. |
| Dr. Mariana Piuri | Reporter Mycobacteriophages for Detection of M. tuberculosis in Clinical Samples and Rapid Determination of Antibiotic Susceptibility | 2:40 – 3:10 p.m. | 9:40 – 10:10 p.m. | 8:40 – 9:10 a.m. |
| Dr. Ayman El-Shibiny | Phage Therapy: A Solution to Antibiotic Resistance in Africa | 3:10 – 3:40 p.m. | 10:10 – 10:40 p.m. | 9:10 – 9:40 a.m. |
| Q&A Session | 3:40 – 3:55 p.m. | 10:40 – 10:55 p.m. | 9:40 – 9:55 a.m. | |
| Dr. Pilar García | Closing of Webinar | 3:55 – 4:00 p.m. | 10:55 – 11:00 p.m. | 9:55 – 10:00 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Pilar Garcia, Dairy Research Institute of Asturias, IPLA-CSIC, Spain;
- Dr. Hui Zhang, Jiangsu Academy of Agricultural Sciences (JAAS), Nanjing, China;
- Dr. Mariana Piuri, Universidad de Buenos Aires, Argentina;
- Dr. Ayman El-Shibiny, Zewail City of Science and Technology, El Cairo, Egypt.
Relevant Special Issue:
Beyond Phages: Exploring Endolysins as Key Players in the Future of Antibacterial Therapeutics
Guest Editor: Dr. Pilar García Suárez
Deadline for manuscript submissions: 31 December 2024
16 October 2024
MDPI's Newly Launched Journals in September 2024
Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.
We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.
We invite you to explore and learn more about these new journals below.
| Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
 |
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue | biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article |
 |
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue | surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article |
 |
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue | ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article |
 |
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue | hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article |
 |
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue | lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
15 October 2024
MDPI Webinar | World Food Day Webinar 2024, 16 October 2024
In celebration of World Food Day 2024, MDPI is launching a special webinar to encourage researchers to unite, take action, and showcase how collective knowledge can address the pressing challenges of food security, sustainable agriculture, and resource management.
World Food Day, led by the Food and Agriculture Organization of the United Nations (FAO), aims to foster awareness about the importance of food security and the urgent need to eradicate hunger worldwide. In line with this mission, our upcoming webinar invites researchers and experts to discuss innovative solutions for achieving sustainable agriculture, improving resource management, and tackling food insecurity worldwide.
We are very much looking forward to seeing you at MDPI World Food Day Webinar 2024. Please find below an up-to-date outline of the presenters.
Date: 16 October 2024 at 01.30 p.m. CEST | 7:30 a.m. EDT | 7:30 p.m. CST Asia
Webinar ID: 835 7950 1147
Webinar Secretariat: [email protected]
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will inform you when the recording is available.
Register now for free!
| Speaker/Presentation | Time in CEST | Time in EDT |
| MDPI Introduction | 1:30 p.m.–1:40 p.m. | 7:30 a.m.–7:40 a.m. |
| Prof. Dr. Giorgia Spigno Valorisation of Food Residues for the Food Industry: Opportunities and Challenges |
1:40 p.m.–2:10 p.m. | 7:40 a.m.–8:10 a.m. |
| Prof. Dr. Ramakrishnan Ramanathan Technological Approaches for Reducing Food Waste |
2:10 p.m.–2:40 p.m. | 8:10 a.m.–8:40 a.m. |
| Q&A Session | 2:40 p.m.–2:55 p.m. | 8:40 a.m.–8:55 a.m. |
| Closing of Webinar | 2:55 p.m.–3:00 p.m. | 8:55 a.m.–9:00 a.m. |
Keynote Speakers:
- Prof. Dr. Giorgia Spigno, Department for Sustainable Food Process, Department for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy;
- Prof. Dr. Ramakrishnan Ramanathan, Department of Management, College of Business Administration, University of Sharjah, Sharjah, United Arab Emirates.
4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)
On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.
It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!
Today’s youth are not just the leaders of tomorrow – they are already leading the change today.
Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”
MDPI Supports the Future Generation of Scientists
This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.
Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.
Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).
“We aim to address pressing global challenges”
MDPI and the SDGs
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.
During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.
Impactful Research
Presenting at the 1st International Conference of Environmental Medicine
In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.
The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.
The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.
MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.
“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”
The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.
Nobel Laureates’ Contributions to MDPI
As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.
Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.
Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.
MDPI’s Presence in Italy
Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.
We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.
Inside MDPI
Celebrating Peer Review Week, 23–27 September 2024
As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.
“We remain committed to enhancing the peer review process”
The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.
Peer Review Innovation and Technology at MDPI
Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.
Listening to MDPI’s Authors and Reviewers
We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.
We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:
Coming Together for Science
ICM 2024 – Advances in Material Innovation
I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.
This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.
We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.
A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.
Upcoming In-Person Event
7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
Reflections from OASPA 2024 Conference in Lisbon (16–18 September)
Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.
“I believe that publishers have a lot to offer in terms of data and insights”
Main Themes from OASPA 2024
The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.
It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.
It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.
While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.
It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.
An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.
Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.
Chief Executive Officer
MDPI AG
